Human Calpain 6 (CAPN6) activation kit by CRISPRa

CAT#: GA100580

CAPN6 CRISPRa kit - CRISPR gene activation of human calpain 6



Find the corresponding CRISPRi Inhibitor Kit

Product Images

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol CAPN6
Locus ID 827
Kit Components

GA100580G1, Calpain 6 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA100580G2, Calpain 6 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA100580G3, Calpain 6 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_014289
UniProt ID Q9Y6Q1
Synonyms CalpM; CANPX; CAPNX; DJ914P14.1
Summary Calpains are ubiquitous, well-conserved family of calcium-dependent, cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large subunit possesses a cysteine protease domain, and both subunits possess calcium-binding domains. Calpains have been implicated in neurodegenerative processes, as their activation can be triggered by calcium influx and oxidative stress. The protein encoded by this gene is highly expressed in the placenta. Its C-terminal region lacks any homology to the calmodulin-like domain of other calpains. The protein lacks critical active site residues and thus is suggested to be proteolytically inactive. The protein may play a role in tumor formation by inhibiting apoptosis and promoting angiogenesis. [provided by RefSeq, Nov 2009]

Documents

Other Versions